Drug-Resistant Infections in the Community: Consequences for Public Health |
The full committee held a hearing to examine the public health consequences of infections of methicillin-resistant Staphylococcus aureus (MRSA) outside of hospitals and other healthcare settings, including the measures people can take to reduce the risk of MRSA infections and what these infections tell us about the public health challenges in addressing such infections. A transcript of this hearing is now available. The following witnesses testified: Panel I:
Panel II:
|
Committee On Oversight and Government Reform
U.S. House of Representatives | 2157 Rayburn House Office Building | Washington, D.C. 20515 | (202) 225-5051